During the past decade, Kempenhaeghe conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kempenhaeghe" #1 sponsor was "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 2 trials, followed by "Eisai Inc." with 1 trials sponsored, "Epilepsiecentrum Kempenhaeghe" with 1 trials sponsored, "LivaNova" with 1 trials sponsored and "Maastricht University Medical Center" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kempenhaeghe" #1 collaborator was "Epilepsiecentrum Kempenhaeghe" with 1 trials as a collaborator, "Maastricht University Medical Center" with 1 trials as a collaborator and "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kempenhaeghe" are "Dravet Syndrome" (3 trials), "Drug Resistant Epilepsy" (1 trials), "Electrical Status Epilepticus During Slow Wave Sleep" (1 trials), "Epilepsy" (1 trials) and "Epileptic Encephalopathy" (1 trials). Many other conditions were trialed in "Kempenhaeghe" in a lesser frequency.

Most popular intervention types in "Kempenhaeghe" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "ZX008 (Fenfluramine Hydrochloride)" (3 trials), "Matching Placebo" (1 trials), "Perampanel" (1 trials), "Vagus Nerve Stimulation (VNS) Therapy" (1 trials) and "Vagus Nerve Stimulator: Neurocybernetic prothesis NCP, Cyberonics Inc., Webster, TX, USA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kempenhaeghe" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Kempenhaeghe". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kempenhaeghe, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kempenhaeghe, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".